Skip to main content
Premium Trial:

Request an Annual Quote

Cancer Genetics Lays Off Staff

NEW YORK (GenomeWeb) – Cancer Genetics announced after the close of the market on Friday that it is laying off an undisclosed number of employees and restructuring its functions. 

The moves are part of an effort to consolidate and reduce costs related to administrative, finance, and operational support functions. 

Additionally, Cancer Genetics said that Edward Sitar will leave the firm as chief financial officer and treasurer, effective Feb. 3. Victor Cross, who joined the firm in October 2016, has been promoted to chief accounting officer. Cross and Chief Operating officer and Executive Vice President of Finance John Roberts will take over Sitar's responsibilities. 

The company said that the moves are expected to positively impact its income statement in the second quarter.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more